Drug class
Nicotinic acetylcholine-receptor partial agonist; smoking-cessation agent
Mechanism of action
A plant-derived alkaloid with activity at nicotinic acetylcholine receptors, principally α4β2. It competes with nicotine for receptor binding but stimulates the receptor less strongly, helping reduce nicotine withdrawal and craving.
General use cases
- Smoking cessation and reduction of nicotine cravings in adults who intend to stop using nicotine-containing products; the cited UK SmPC specifies a 25-day course and product-specific restrictions
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
